Susquehanna International Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-850
| Closed | -$5.73K | – | 6886 |
|
|
2023
Q4 | $5.73K | Buy |
850
+127
| +18% | +$856 | ﹤0.01% | 5767 |
|
|
2023
Q3 | $6.62K | Sell |
723
-658
| -48% | -$6.02K | ﹤0.01% | 5360 |
|
|
2023
Q2 | $29.2K | Buy |
1,381
+736
| +114% | +$15.5K | ﹤0.01% | 5303 |
|
|
2023
Q1 | $17.4K | Buy |
645
+300
| +87% | +$8.08K | ﹤0.01% | 5639 |
|
|
2022
Q4 | $12.2K | Sell |
345
-67
| -16% | -$2.37K | ﹤0.01% | 5451 |
|
|
2022
Q3 | $93K | Sell |
412
-217
| -34% | -$49K | ﹤0.01% | 5307 |
|
|
2022
Q2 | $119K | Buy |
+629
| New | +$119K | ﹤0.01% | 4913 |
|
|
2022
Q1 | – | Sell |
-1,597
| Closed | -$249K | – | 6724 |
|
|
2021
Q4 | $249K | Buy |
1,597
+4
| +0.3% | +$624 | ﹤0.01% | 4718 |
|
|
2021
Q3 | $319K | Buy |
1,593
+291
| +22% | +$58.3K | ﹤0.01% | 4236 |
|
|
2021
Q2 | $333K | Buy |
+1,302
| New | +$333K | ﹤0.01% | 4348 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5889 |
|
|
2020
Q4 | – | Sell |
-2,592
| Closed | -$633K | – | 5415 |
|
|
2020
Q3 | $633K | Buy |
+2,592
| New | +$633K | ﹤0.01% | 2772 |
|
|
2020
Q2 | – | Sell |
-588
| Closed | -$120K | – | 5112 |
|
|
2020
Q1 | $120K | Buy |
+588
| New | +$120K | ﹤0.01% | 3996 |
|
|
2019
Q4 | – | Sell |
-471
| Closed | -$145K | – | 4991 |
|
|
2019
Q3 | $145K | Sell |
471
-835
| -64% | -$257K | ﹤0.01% | 3976 |
|
|
2019
Q2 | $415K | Sell |
1,306
-1,725
| -57% | -$548K | ﹤0.01% | 3127 |
|
|
2019
Q1 | $1.27M | Buy |
3,031
+1,466
| +94% | +$615K | ﹤0.01% | 1120 |
|
|
2018
Q4 | $477K | Buy |
+1,565
| New | +$477K | ﹤0.01% | 2178 |
|
|
2017
Q3 | – | Sell |
-480
| Closed | -$114K | – | 4423 |
|
|
2017
Q2 | $114K | Buy |
+480
| New | +$114K | ﹤0.01% | 3223 |
|
|
2016
Q1 | – | Sell |
-41
| Closed | -$27K | – | 4515 |
|
|
2015
Q4 | $27K | Sell |
41
-35
| -46% | -$23K | ﹤0.01% | 4093 |
|
|
2015
Q3 | $36K | Sell |
76
-360
| -83% | -$171K | ﹤0.01% | 4062 |
|
|
2015
Q2 | $248K | Buy |
436
+325
| +293% | +$185K | ﹤0.01% | 3914 |
|
|
2015
Q1 | $947K | Buy |
111
+88
| +383% | +$751K | ﹤0.01% | 2497 |
|
|
2014
Q4 | $199K | Buy |
+23
| New | +$199K | ﹤0.01% | 4017 |
|